Is a Russian, dynamically growing pharmaceutical company with a headquarter office in Moscow. Since its foundation in 2013 our main focus has been on hospital and reimbursement segment of public healthcare system. Today we distribute prescription drugs and medical devices to each region of Russian Federation in accordance to the best practices and  GDP standards. We do business in strategic alliance and partnership with major drug and device manufacturers. Based on the reported earnings in 2018 Pharmforward is rated among biggest Russian drug distributors with steady double digit CAGR performance.

While growing professionally we have naturally developed new competences – today in addition to the full distribution services we are happy to offer our esteemed partners a full range of flexible support in regulatory affairs, clinical and medical affairs as well as in manufacturing capabilities with professional project management in relevant technology transfer to the numerous Russian or Eurasian manufacturing sites.

  • Russian Drugs Procurement has reached 475 Bln RUR (2018) with CAGR 7%
  • Since its foundation in 2013 Pharmforward has been performing with CAGR of 174% (2013-2018)
  • Pharmforward’s Evolution Index is 1,14 (2015 - 2018)